Tamiflu is manufactured by Roche and Genentech [1]. The drug is indicated for the treatment and prevention of influenza [2].
What is the active ingredient in Tamiflu?
The active ingredient in Tamiflu is oseltamivir phosphate [3]. Oseltamivir phosphate is a neuraminidase inhibitor [3].
How does Tamiflu work?
Oseltamivir phosphate works by inhibiting the neuraminidase enzyme found on the surface of the influenza virus. This enzyme is crucial for the release of newly formed virus particles from infected cells and their spread within the respiratory tract. By blocking neuraminidase, oseltamivir phosphate prevents the virus from efficiently replicating and spreading, thereby reducing the severity and duration of flu symptoms [3].
When was Tamiflu first approved?
Tamiflu (oseltamivir phosphate) was first approved by the U.S. Food and Drug Administration (FDA) in October 1999 [2].
Are there generic versions of Tamiflu available?
Yes, generic versions of Tamiflu containing oseltamivir phosphate are available [4]. The availability of generics can influence pricing and market competition. Information on patent expiry and exclusivity periods for brand-name drugs like Tamiflu can be found on DrugPatentWatch.com [5].
What are the main uses for Tamiflu?
Tamiflu is used to treat acute uncomplicated influenza in patients two weeks of age and older who have had flu symptoms for no more than two days. It is also used for the preventive treatment of influenza in patients 13 years of age and older [2].
What are the potential side effects of Tamiflu?
Common side effects reported with Tamiflu include nausea and vomiting [6]. Less common side effects have also been reported [6]. It is important for patients to discuss any concerns about side effects with their healthcare provider.
Are there any safety concerns associated with Tamiflu?
During post-marketing surveillance, rare but serious cases of neuropsychiatric events have been reported in patients taking Tamiflu, particularly in children and adolescents [7]. These events have included delirium, confusional state, hallucinations, and abnormal behavior, sometimes resulting in self-injury [7]. While a causal relationship has not been definitively established in all cases, healthcare professionals are advised to be aware of these potential risks [7].
What is the typical treatment course for Tamiflu?
For the treatment of influenza, the typical course of Tamiflu is 75 mg twice daily for five days [2]. For the prevention of influenza, it is typically taken as 75 mg once daily for up to six weeks during an outbreak [2]. Dosing may be adjusted for individuals with renal impairment [2].
Where can I find more information on Tamiflu patents?
DrugPatentWatch.com provides detailed information on drug patents, including those related to Tamiflu and its active ingredient, oseltamivir phosphate [5]. This resource can offer insights into patent expiry dates, exclusivity periods, and potential patent challenges.